Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.930 | 6.930 | 0.000 |
Shares | 93.280 | 93.280 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.017 | 20.001 |
Price to Book | 5.780 | 4.086 |
Price to Sales | 5.013 | 2.440 |
Price to Cash Flow | 16.037 | 16.387 |
Dividend Yield | 1.285 | 1.366 |
5 Years Earnings Growth | 10.419 | 12.512 |
Number of long holdings: 28
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 8.36 | 481.16 | -1.49% | |
Gilead | US3755581036 | 8.27 | 98.04 | -1.62% | |
Regeneron Pharma | US75886F1075 | 6.95 | 722.07 | +0.75% | |
Amgen | US0311621009 | 6.66 | 297.78 | -3.26% | |
Eli Lilly | US5324571083 | 6.51 | 870.37 | +3.35% | |
Novo Nordisk B | DK0062498333 | 6.39 | 635.0 | +2.50% | |
Intuitive Surgical | US46120E6023 | 5.95 | 588.50 | -0.41% | |
Neurocrine | US64125C1099 | 4.89 | 150.51 | -0.46% | |
Boston Scientific | US1011371077 | 4.68 | 105.02 | +0.05% | |
Lonza Group | CH0013841017 | 4.33 | 613.00 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Taiwan Superior Equity Fund | 24.42B | 22.19 | 11.00 | 18.75 | ||
Nomura Taiwan Small Cap Fund | 9.92B | 23.21 | 12.79 | 19.44 | ||
Nomura Global Equity Fund TWD | 8.71B | 29.45 | 9.01 | 11.33 | ||
Nomura Taiwan Growth Fund | 2.83B | 22.72 | 14.19 | 18.30 | ||
Nomura Taiwan Aggressive Growth Sel | 2.1B | 22.70 | 14.17 | 18.54 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review